Sheng Hu

20PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 03, 2026
The Predictive Value of Neutrophil-To-Lymphocyte Ratio (NLR) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA-IIIB Non-Small Cell Lung Cancer in Real-World Practice.

|Mar 26, 2026
Temporal Disease Sequence and Prognostic Outcomes in Patients with Coexisting Lung Cancer and Tuberculosis: A 123-Patient Retrospective Cohort Study.

Wenfeng Yu, Haoran Xie, Bo Ye

|Aug 14, 2025
Compared with assessment via endoscopic examination, assessment through the examination of resected regional lymph nodes can significantly reduce the mortality rate of lung cancer patients: a retrospective study of 222,563 participants from the SEER database.

Jiayue Ye, Yucheng Ma, Jiacong Liu

|Dec 18, 2024
Effect of Levosimendan on Low Cardiac Output Syndrome After Pericardiectomy.

Likui Fang, Pengfei Zhu, Guocan Yu

|Dec 16, 2024
Major pathologic response predicts survival in resectable stage IIIA non-small cell lung cancer after neoadjuvant therapy.

Shihong Zhou, Ying Zhang, Ziheng Wu

|Feb 20, 2024
Schizandrin A induces non-small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation.

Linhai Zhu, Yanye Wang, Xuhua Huang

Pageof 4

Frequent Collaborators

3 joint publications

Guocan Yu

2 joint publications

Xuhua Huang

1 joint publications

Weidong Wang

1 joint publications

Zhehao He